Developer docs
API playgroundTry for free, no card

Search company profiles

Partner Fund Management

Full company profile

uuid003adak

Namestring
Partner Fund Management
Legal namestring
PFM Health Sciences, LP
Websiteurl
pfmlp.com
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Partner Fund Management operates PFM Health Sciences, LP, a privately-held healthcare-focused investment advisory firm founded in 2004 and headquartered in San Francisco, California. The firm manages both public and private investments on behalf of institutional capital providers, deploying capital into biopharma, medical technology, life science, and healthcare service companies across the capital structure. Founding Partner and Chief Investment Officer Brian Grossman leads the firm, with William R. Goodell serving as Chief Operating Officer. Christopher James is also identified as a founder of the broader Partner Fund Management entity.

The firm's investment philosophy emphasizes a specialist, bottom-up, fundamental approach to the healthcare sector, capitalizing on the intersection of secular healthcare innovation, domain expertise, and demographic trends. It offers the flexibility to invest in both public and private companies, which the firm positions as a structural advantage relative to single-asset-class competitors. Portfolio construction and risk management are designed to dampen volatility while targeting an attractive return/risk profile, with stated commitments to measurable health-outcome impact and responsible stewardship of institutional capital.

Revenue mechanics for PFM Health Sciences are not publicly disclosed and are consistent with the standard institutional investment advisor model: management fees on assets under management and performance fees on fund returns, with no public pricing schedule. Customer acquisition occurs through direct institutional relationships rather than broad marketing channels. The firm does not offer discrete branded products or technology platforms, and serves a dual customer base of healthcare companies seeking specialized capital partners and institutional investors seeking healthcare sector exposure.

Short descriptiontext

Partner Fund Management operates PFM Health Sciences, a privately-held investment advisor founded in 2004 that manages public and private healthcare investments on behalf of institutional capital providers, targeting biopharma, medtech, life sciences, and healthcare service companies.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
healthcare investment management, biopharma investment advisory, medical technology investing, institutional asset management, public equity investments
NAICS code2 codes
  • Portfolio Management and Investment Advice52394
  • Portfolio Management and Investment Advice523940
SIC code1 code
  • Investment Advice6282
Product category
Healthcare Investment Management
Social media profiles1 record
Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Partner Fund Management (PFM), operating primarily through its healthcare-focused subsidiary PFM Health Sciences, provides investment advisory services to pooled investment vehicles. Founded in 2004 and led by Founding Partner and CIO Brian Grossman, the firm manages public and private investments in biopharma, medical technology, life science, and healthcare service companies using a specialized, bottom-up, fundamental approach.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

PFM Health Sciences is a healthcare-focused investment advisory firm that does not offer distinct product brands or named modules. The firm provides investment management services spanning public and private equity investments in biopharma, medical technology, life science, and healthcare service companies. Its service is delivered as a unified advisory offering under the PFM Health Sciences brand, managed by Founding Partner and CIO Brian Grossman. No discrete product lines, platforms, or modules are named in the available source material.

Product and service1 record
1Healthcare Investment Advisory Services
CategoryHealthcare Investment Management
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight2 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

Healthcare-focused crossover fund investing across public and private biopharma and medtech. Directly comparable to PFM's specialist, full-capital-structure healthcare mandate.

TypeDirect peer
Description

Healthcare-focused hedge fund investing in biopharma and medtech public equities with selective private exposure. Mirrors PFM's healthcare-specialist fund structure.

TypeDirect peer
Description

Healthcare and life-sciences-focused investment manager with public/private crossover exposure. Directly comparable to PFM's vertical-specialist positioning.

TypeBroad incumbent
Description

Large global asset manager with dedicated healthcare equity strategies among a much broader product set. Comparable as a healthcare investor but not a vertical specialist like PFM.

TypeDirect peer
Description

Biotech-focused investment manager deploying capital across public equities and private rounds in clinical-stage life sciences companies. Strong analog for PFM's specialist healthcare mandate.

TypeDirect peer
Description

One of the largest healthcare-dedicated investment firms, managing public and private capital across biopharma, medtech, and diagnostics globally. Highly comparable to PFM's healthcare-specialist, public-plus-private mandate.

TypeDirect peer
Description

Healthcare and biotech-focused investment firm with crossover public/private strategies. Comparable to PFM in sector focus and flexible capital-structure approach.

8Baker Bros. Advisors
TypeDirect peer
Description

Long-tenured, healthcare-only investment advisor with deep public and private biotech exposure. Closely mirrors PFM's pure-play healthcare thesis and founder-led structure.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment32 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Partner Fund Management

Healthcare Investment Managementpfmlp.com

Partner Fund Management operates PFM Health Sciences, a privately-held investment advisor founded in 2004 that manages public and private healthcare investments on behalf of institutional capital providers, targeting biopharma, medtech, life sciences, and healthcare service companies.

What Partner Fund Management does

Partner Fund Management operates PFM Health Sciences, LP, a privately-held healthcare-focused investment advisory firm founded in 2004 and headquartered in San Francisco, California. The firm manages both public and private investments on behalf of institutional capital providers, deploying capital into biopharma, medical technology, life science, and healthcare service companies across the capital structure. Founding Partner and Chief Investment Officer Brian Grossman leads the firm, with William R. Goodell serving as Chief Operating Officer. Christopher James is also identified as a founder of the broader Partner Fund Management entity.

The firm's investment philosophy emphasizes a specialist, bottom-up, fundamental approach to the healthcare sector, capitalizing on the intersection of secular healthcare innovation, domain expertise, and demographic trends. It offers the flexibility to invest in both public and private companies, which the firm positions as a structural advantage relative to single-asset-class competitors. Portfolio construction and risk management are designed to dampen volatility while targeting an attractive return/risk profile, with stated commitments to measurable health-outcome impact and responsible stewardship of institutional capital.

Revenue mechanics for PFM Health Sciences are not publicly disclosed and are consistent with the standard institutional investment advisor model: management fees on assets under management and performance fees on fund returns, with no public pricing schedule. Customer acquisition occurs through direct institutional relationships rather than broad marketing channels. The firm does not offer discrete branded products or technology platforms, and serves a dual customer base of healthcare companies seeking specialized capital partners and institutional investors seeking healthcare sector exposure.

Partner Fund Management firmographics

Firmographics
Name
Partner Fund Management
Legal name
PFM Health Sciences, LP
Website
https://pfmlp.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
11–50 employees
Short description
Partner Fund Management operates PFM Health Sciences, a privately-held investment advisor founded in 2004 that manages public and private healthcare investments on behalf of institutional capital providers, targeting biopharma, medtech, life sciences, and healthcare service companies.
Ownership category
akta.pro rank

Where Partner Fund Management is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Markets served

Partner Fund Management business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Partner Fund Management product offering

Product offering

Core offering

Partner Fund Management (PFM), operating primarily through its healthcare-focused subsidiary PFM Health Sciences, provides investment advisory services to pooled investment vehicles. Founded in 2004 and led by Founding Partner and CIO Brian Grossman, the firm manages public and private investments in biopharma, medical technology, life science, and healthcare service companies using a specialized, bottom-up, fundamental approach.

Product overview

PFM Health Sciences is a healthcare-focused investment advisory firm that does not offer distinct product brands or named modules. The firm provides investment management services spanning public and private equity investments in biopharma, medical technology, life science, and healthcare service companies. Its service is delivered as a unified advisory offering under the PFM Health Sciences brand, managed by Founding Partner and CIO Brian Grossman. No discrete product lines, platforms, or modules are named in the available source material.

Differentiator

Problem solved

Functional benefit

Products and services

  • Healthcare Investment Advisory Services

Companies that use Partner Fund Management

Customer profile

Segments2 records

Ideal customer profiles2 records

Partner Fund Management technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Partner Fund Management partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves2 records

Expansion highlights2 records

Partner Fund Management competitors and assessment

Company assessment

Direct peers

  • RA Capital Management: Healthcare-focused crossover fund investing across public and private biopharma and medtech. Directly comparable to PFM's specialist, full-capital-structure healthcare mandate.
  • Cormorant Asset Management: Healthcare-focused hedge fund investing in biopharma and medtech public equities with selective private exposure. Mirrors PFM's healthcare-specialist fund structure.
  • Casdin Capital: Healthcare and life-sciences-focused investment manager with public/private crossover exposure. Directly comparable to PFM's vertical-specialist positioning.
  • EcoR1 Capital: Biotech-focused investment manager deploying capital across public equities and private rounds in clinical-stage life sciences companies. Strong analog for PFM's specialist healthcare mandate.
  • Orbimed Advisors: One of the largest healthcare-dedicated investment firms, managing public and private capital across biopharma, medtech, and diagnostics globally. Highly comparable to PFM's healthcare-specialist, public-plus-private mandate.
  • Perceptive Advisors: Healthcare and biotech-focused investment firm with crossover public/private strategies. Comparable to PFM in sector focus and flexible capital-structure approach.
  • Baker Bros. Advisors: Long-tenured, healthcare-only investment advisor with deep public and private biotech exposure. Closely mirrors PFM's pure-play healthcare thesis and founder-led structure.

Broad incumbents

  • Janus Henderson Investors: Large global asset manager with dedicated healthcare equity strategies among a much broader product set. Comparable as a healthcare investor but not a vertical specialist like PFM.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Partner Fund Management social profiles

Digital presence

Partner Fund Management financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Partner Fund Management leadership team

Management profile

Number of profiles

Profiles3 records

Partner Fund Management funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Partner Fund Management M&A and investment

M&A and investment

M&A

Investments32 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Partner Fund Management

What does Partner Fund Management do?

Partner Fund Management (PFM), operating primarily through its healthcare-focused subsidiary PFM Health Sciences, provides investment advisory services to pooled investment vehicles. Founded in 2004 and led by Founding Partner and CIO Brian Grossman, the firm manages public and private investments in biopharma, medical technology, life science, and healthcare service companies using a specialized, bottom-up, fundamental approach.

Is Partner Fund Management a public or private company?

Partner Fund Management is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Partner Fund Management founded?

Partner Fund Management was founded in 2004. It employs 11 to 50 people.

Where is Partner Fund Management based?

Partner Fund Management is headquartered in San Francisco, United States, in the North America region.

Who are Partner Fund Management's main competitors?

Direct peers on record are RA Capital Management, Cormorant Asset Management, Casdin Capital, EcoR1 Capital, Orbimed Advisors, Perceptive Advisors and Baker Bros. Advisors. Janus Henderson Investors is listed as a broad incumbent.

Does Partner Fund Management have an API?

No public API is recorded for Partner Fund Management.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinSMEsAuris Health Raises $220M in Growth FinancingAuris Health closed a $220M equity financing round led by Partner Fund Management, with participation from Wellington, D1 Capital, and others. The company, which has raised over $700M total, will use the funds to advance its Monarch Platform and robotic interventional technology. The platform is FDA-cleared for bronchoscopic procedures.GlobeNewswireAllakos Secures $100 Million In Series B FinancingAllakos completed a $100 million Series B financing led by New Enterprise Associates, with participation from Redmile Group, Partner Fund Management, and others. Proceeds will advance its lead candidate AK002 in eosinophilic gastroenteritis and other indications, and support preclinical programs.TechCrunchTheranos reaches settlement with investor Partner Fund ManagementTheranos settled with hedge fund Partner Fund Management, dismissing all claims against the company and its officers. The settlement allows Theranos to proceed with its tender offer and focus on its miniLab product. The company still faces other lawsuits, including one from Walgreens.WsjTheranos Secretly Bought Outside Lab Gear and Ran Fake Tests, Court Filings AllegeCourt filings allege Theranos misled directors about lab practices, secretly bought commercial equipment, and ran fake demonstration tests for investors. The accusations come from depositions of 22 former employees or directors in a suit by Partner Fund Management LP.WsjTheranos Secretly Bought Outside Lab Gear and Ran Fake Tests, Court Filings AllegeCourt filings in a suit by Partner Fund Management LP allege Theranos misled directors about its lab practices, secretly bought commercial equipment, and ran fake demonstration tests for investors. The accusations rely on testimony from 22 former employees or directors deposed by the hedge fund.TechCrunchThe SEC gets the case it’s been waiting for in Silicon ValleyThe SEC is aggressively pursuing enforcement actions against Silicon Valley startups, with Theranos emerging as the flagship case it has long sought to expand its regulatory reach into the private market startup ecosystem. Partner Fund Management filed a $96.1 million lawsuit against Theranos last week, alleging the company knowingly deceived investors about its technology capabilities and regulatory status, while Theranos founder Elizabeth Holmes has been banned from operating blood-testing labs for two years. The SEC is simultaneously investigating Hampton Creek for allegedly inflating product sales to raise additional funding and examining Lending Club's historical lending practices, signaling heightened scrutiny of startup fundraising practices under a potential Clinton administration.VC News DailySienna Biopharmaceuticals Inks Series A-2Sienna Biopharmaceuticals completed a second closing of its Series A financing, raising an additional $12 million in equity capital and bringing the total raised to approximately $46 million. The funding round was led by existing investors ARCH Venture Partners and Partner Fund Management with participation from new investor Two River, targeted to fund pharmaceutical research and business development. The company's lead technology, Silver Plasmonic Therapy, is being developed for acne and permanent hair removal applications with clinical trials already underway.FinSMEsSienna Biopharmaceuticals Raises $12M in Second Close of Series A FundingSienna Biopharmaceuticals raised $12M in its second Series A close, led by existing investors Arch Venture Partners and Partner Fund Management with new investor Two River. The company has raised about $46M total and will use the funds for pharmaceutical research and business development. Its lead technology, Silver Plasmonic Therapy, targets acne and permanent hair removal.FinSMEsAllena Pharmaceuticals Completes $53M Series C FinancingAllena Pharmaceuticals completed a $53M Series C financing led by Partner Fund Management, with participation from Fidelity and Wellington. The company will use the proceeds to advance its lead product candidate ALLN-177 into Phase 3 trials for secondary hyperoxaluria and explore additional indications. It has raised a total of $96M in equity financing.